Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-02

Clinical Trial Update: Peppermint Oil for the Treatment of Irritable Bowel Syndrome: Optimizing Therapeutic Strategies Using Targeted Delivery [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating targeted delivery of peppermint oil for irritable bowel syndrome with abdominal pain has completed, exploring optimized therapeutic s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Peppermint oil (mentha piperita oil)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Irritable Bowel Syndrome, Abdominal Pain | Phase 3 | Status: COMPLETED